(Q34469951)

2 August 2017

1 reference

title

Quantifying the effect of folic acid (English)

1 reference

2 August 2017

1 reference

N J Wald

1

1 reference

2 August 2017

M R Law

series ordinal

2

1 reference

2 August 2017

J K Morris

series ordinal

3

1 reference

2 August 2017

D S Wald

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

358

1 reference

2 August 2017

9298

1 reference

2 August 2017

2069-2073

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

2 August 2017

1 reference

7 January 2021

Folic acid and the prevention of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Fortification with low amounts of folic acid makes a significant difference in folate status in young women: implications for the prevention of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Quantitative responses of serum folate to increasing intakes of folic acid in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Effect of long-term supplementation of folate on folate status in plasma and erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Randomized trial of folic acid supplementation and serum homocysteine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Dietary strategies for lowering homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Vitamin requirements for the treatment of hyperhomocysteinemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Folate levels and neural tube defects. Implications for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Folic acid food fortification to prevent neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Trends in serum folate after food fortification.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Further experience of vitamin supplementation for prevention of neural tube defect recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Quantifying the decline in the birth prevalence of neural tube defects in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

Folic acid, pernicious anaemia, and prevention of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907104-5

7 January 2021

10.1016/S0140-6736(01)07104-5

Identifiers

DOI

1 reference

2 August 2017

1 reference